BR0210776A - Compostos de imunomodulação - Google Patents
Compostos de imunomodulaçãoInfo
- Publication number
- BR0210776A BR0210776A BR0210776-7A BR0210776A BR0210776A BR 0210776 A BR0210776 A BR 0210776A BR 0210776 A BR0210776 A BR 0210776A BR 0210776 A BR0210776 A BR 0210776A
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- compound
- immunomodulation
- relates
- present
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 230000002519 immonomodulatory effect Effects 0.000 title abstract 3
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 abstract 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 abstract 2
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 2
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
"COMPOSTOS DE IMUNOMODULAçãO". A presente invenção refere-se ao novo composto heterocíclico, uma composição farmacêutica compreendendo o referido composto, um método e uso do referido composto para o tratamento clínico das condições médicas que podem beneficiarem-se da imunomodulação, por exemplo, artrite reumatóide, esclerose múltipla, diabetes, asma, transplante, lúpus eritematoso sistêmico e psoríase. Mais particularmente, a presente invenção refere-se aos novos compostos heterocíclicos, que são antagonistas de CD28 capazes de inibir as interações entre CD80 e CD28.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0102404A SE0102404D0 (sv) | 2001-07-04 | 2001-07-04 | Novel immunomodulating compounds |
| PCT/SE2002/001309 WO2003004495A1 (en) | 2001-07-04 | 2002-07-02 | Novel immunomodulating compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0210776A true BR0210776A (pt) | 2004-07-20 |
Family
ID=20284743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0210776-7A BR0210776A (pt) | 2001-07-04 | 2002-07-02 | Compostos de imunomodulação |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1409485B1 (pt) |
| JP (1) | JP2005501033A (pt) |
| CN (1) | CN1249063C (pt) |
| AT (1) | ATE324373T1 (pt) |
| AU (1) | AU2002315996B2 (pt) |
| BR (1) | BR0210776A (pt) |
| CA (1) | CA2451749A1 (pt) |
| DE (1) | DE60210977T2 (pt) |
| ES (1) | ES2258150T3 (pt) |
| HK (1) | HK1066809A1 (pt) |
| HR (1) | HRP20031055B1 (pt) |
| HU (1) | HUP0401204A3 (pt) |
| MX (1) | MXPA04000017A (pt) |
| NO (1) | NO20035684L (pt) |
| NZ (1) | NZ530316A (pt) |
| PL (1) | PL367637A1 (pt) |
| RU (1) | RU2004103079A (pt) |
| SE (1) | SE0102404D0 (pt) |
| WO (1) | WO2003004495A1 (pt) |
| YU (1) | YU101603A (pt) |
| ZA (1) | ZA200309806B (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1562944B1 (en) * | 2002-11-22 | 2007-02-14 | Active Biotech AB | Pyrazoloquinolines with immunomodulating activity |
| ATE425164T1 (de) | 2002-12-16 | 2009-03-15 | Active Biotech Ab | Tetrazyklische immunmodulierende verbindungen |
| GB0305876D0 (en) * | 2003-03-14 | 2003-04-16 | Avidex Ltd | Immuno inhibitory heterocyclic compounds |
| EP2284172A1 (en) * | 2003-03-14 | 2011-02-16 | MediGene Ltd. | Immunomodulating heterocyclic compounds |
| GB0325644D0 (en) | 2003-11-04 | 2003-12-10 | Avidex Ltd | Immuno ihibitory pyrazolone compounds |
| CA2553329A1 (en) | 2004-01-14 | 2005-07-28 | Ajinomoto Co., Inc. | New fused polycyclic compounds |
| GB0411770D0 (en) * | 2004-05-26 | 2004-06-30 | Avidex Ltd | Immuno inhibitory heterocyclic compouds |
| DK1776366T3 (da) | 2004-08-09 | 2009-02-16 | Medigene Ltd | Immunomodulerende oxopyrazolocinnoliner som CD80-inhibitorer |
| CN101863903B (zh) * | 2010-06-08 | 2014-03-12 | 沈阳药科大学 | 1,4-二氢噻吩并[3’,2’:5,6]噻喃并[4,3-c]吡唑-3-羧酸衍生物及其应用 |
| BR112015030387B1 (pt) * | 2013-06-24 | 2021-02-09 | Merck Patent Gmbh | compostos de pirazol moduladores de fshr, seus usos, e composição farmacêutica |
| EP2883883A1 (en) | 2013-12-16 | 2015-06-17 | Cardio3 Biosciences S.A. | Therapeutic targets and agents useful in treating ischemia reperfusion injury |
| NZ728298A (en) | 2014-07-08 | 2017-09-29 | Avertana Ltd | Extraction of products from titanium-bearing minerals |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4268516A (en) * | 1978-10-11 | 1981-05-19 | Pfizer Inc. | [1]Benzothiopyrano[4,3-c]pyrazoles as immunoregulatory agents |
| US4312870A (en) * | 1979-06-21 | 1982-01-26 | Ciba-Geigy Corporation | Pyrazoloquinolines |
| GB8818895D0 (en) * | 1988-08-09 | 1988-09-14 | Boots Co Plc | Therapeutic agents |
| PH26314A (en) * | 1988-08-09 | 1994-04-29 | Boots Co Plc | Benzopyrano [4,3-c] pyrazoles derivatives |
| SE8903564D0 (sv) * | 1989-10-26 | 1989-10-26 | Pharmacia Ab | New use condensed quinoline compound |
| BR9105984A (pt) * | 1990-02-02 | 1992-11-10 | Boots Co Plc | Processo de preparacao de derivados do pirazol e de composicoes farmaceuticas que contem os mesmos |
| AR006520A1 (es) * | 1996-03-20 | 1999-09-08 | Astra Pharma Prod | Derivados de 2-arilpirazolisoquinolina y cinolinona y procedimiento para su preparacion. |
-
2001
- 2001-07-04 SE SE0102404A patent/SE0102404D0/xx unknown
-
2002
- 2002-07-02 JP JP2003510662A patent/JP2005501033A/ja not_active Withdrawn
- 2002-07-02 DE DE60210977T patent/DE60210977T2/de not_active Expired - Lifetime
- 2002-07-02 YU YU101603A patent/YU101603A/sh unknown
- 2002-07-02 CN CNB028132890A patent/CN1249063C/zh not_active Expired - Fee Related
- 2002-07-02 AT AT02746260T patent/ATE324373T1/de not_active IP Right Cessation
- 2002-07-02 CA CA002451749A patent/CA2451749A1/en not_active Abandoned
- 2002-07-02 MX MXPA04000017A patent/MXPA04000017A/es active IP Right Grant
- 2002-07-02 RU RU2004103079/04A patent/RU2004103079A/ru not_active Application Discontinuation
- 2002-07-02 NZ NZ530316A patent/NZ530316A/en unknown
- 2002-07-02 EP EP02746260A patent/EP1409485B1/en not_active Expired - Lifetime
- 2002-07-02 BR BR0210776-7A patent/BR0210776A/pt not_active IP Right Cessation
- 2002-07-02 ES ES02746260T patent/ES2258150T3/es not_active Expired - Lifetime
- 2002-07-02 PL PL02367637A patent/PL367637A1/xx not_active Application Discontinuation
- 2002-07-02 HU HU0401204A patent/HUP0401204A3/hu unknown
- 2002-07-02 AU AU2002315996A patent/AU2002315996B2/en not_active Ceased
- 2002-07-02 WO PCT/SE2002/001309 patent/WO2003004495A1/en active IP Right Grant
-
2003
- 2003-12-17 HR HR20031055A patent/HRP20031055B1/xx not_active IP Right Cessation
- 2003-12-19 NO NO20035684A patent/NO20035684L/no not_active Application Discontinuation
- 2003-12-19 ZA ZA200309806A patent/ZA200309806B/en unknown
-
2004
- 2004-12-14 HK HK04109875A patent/HK1066809A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| HK1066809A1 (en) | 2005-04-01 |
| DE60210977T2 (de) | 2006-09-21 |
| NO20035684L (no) | 2004-03-02 |
| NO20035684D0 (no) | 2003-12-19 |
| EP1409485A1 (en) | 2004-04-21 |
| CN1249063C (zh) | 2006-04-05 |
| JP2005501033A (ja) | 2005-01-13 |
| MXPA04000017A (es) | 2004-05-21 |
| EP1409485B1 (en) | 2006-04-26 |
| YU101603A (en) | 2006-05-25 |
| ES2258150T3 (es) | 2006-08-16 |
| WO2003004495A1 (en) | 2003-01-16 |
| HUP0401204A2 (hu) | 2004-10-28 |
| ZA200309806B (en) | 2004-12-20 |
| NZ530316A (en) | 2004-08-27 |
| AU2002315996B2 (en) | 2007-11-29 |
| DE60210977D1 (de) | 2006-06-01 |
| HRP20031055B1 (en) | 2008-01-31 |
| ATE324373T1 (de) | 2006-05-15 |
| CN1522254A (zh) | 2004-08-18 |
| HUP0401204A3 (en) | 2008-03-28 |
| CA2451749A1 (en) | 2003-01-16 |
| HRP20031055A2 (en) | 2004-06-30 |
| PL367637A1 (en) | 2005-03-07 |
| SE0102404D0 (sv) | 2001-07-04 |
| RU2004103079A (ru) | 2005-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0210776A (pt) | Compostos de imunomodulação | |
| BR0305842A (pt) | Mistura curável, e, método | |
| HK1086562A1 (en) | Pyrazoloquinolines with immunomodulating activity | |
| CL2008000762A1 (es) | Compuestos derivados de pirimidinas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la psoriasis, diabetes, artritis reumatoide, entre otras enfermedades ( divisional solicitud 1147-02). | |
| BRPI0413490A (pt) | novos compostos | |
| BR0009651A (pt) | Composto, processo para a preparação de um composto, composição farmacêutica, uso de um composto, e, método para tratar artrite reumatóide e uma doença obstrutiva das vias aéreas | |
| IL163629A0 (en) | Glutaminyl derivatives and pharmaceutical compositions containing the same | |
| DK1436257T3 (da) | Oxim-analogica af 1-alpha, 25-dihydroxy-vitamin-D3 med ringe kalcemisk virkning | |
| BR9707064A (pt) | Novos derivados 19-nor-pregneno | |
| WO2004043954A3 (en) | Trans-9,10-dehydroepothilone c and d, analogs thereof and methos of making the same | |
| NO20076638L (no) | Nye 8-sulfonylamino-3-aminosubstituerte kroman- eller tetrahydronaftalenderivater som modulerer 5HT6-reseptoren | |
| BRPI0607141A2 (pt) | composições de acrilato curáveis, métodos para a fabricação das composições e artigos feitos a partir destas | |
| SE0200919D0 (sv) | Chemical compounds | |
| NO20055752L (no) | N-ureidoalkyl-piperidiner som modulerer forbindelser av kjemokinreseptor-aktivitet | |
| WO2003087062A3 (en) | 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation | |
| PT1383756E (pt) | Derivados de cumarina a utilizar como anticoagulantes | |
| GB0120461D0 (en) | Novel compounds | |
| TR200503401T1 (tr) | Kuetiapin (Quetiapine) Fumarat'ın yeni polimorfları | |
| BRPI0403028A (pt) | Compostos heterocìclicos de oxima, processo para sua preparação e composições farmacêuticas contendo os mesmos | |
| WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
| BRPI0405791A (pt) | Preparados de metal nobre e preparados de lustrina para a serigrafia direta e indireta | |
| AU2003287129A1 (en) | Tetracyclic immunomodulatory compounds | |
| EP1598366B8 (en) | Somatostatin analogues | |
| AU2003227622A1 (en) | Methylthiophene carboxanilides | |
| AU2003242730A1 (en) | 3,3,4,4-tetrafluorocyclopentane compounds, used as components of liquid crystal media |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A E 8A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |